BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 34767832)

  • 1. The characteristics of patients with kidney light chain deposition disease concurrent with light chain amyloidosis.
    Said SM; Best Rocha A; Valeri AM; Paueksakon P; Dasari S; Theis JD; Vrana JA; Obadina MO; Saghafi D; Alexander MP; Sethi S; Larsen CP; Joly F; Dispenzieri A; Bridoux F; Sirac C; Leung N; Fogo AB; McPhail ED; Nasr SH
    Kidney Int; 2022 Jan; 101(1):152-163. PubMed ID: 34767832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney and liver involvement in monoclonal light chain disorders.
    Pozzi C; Locatelli F
    Semin Nephrol; 2002 Jul; 22(4):319-30. PubMed ID: 12118397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The concurrence of light-chain deposition disease, AL-amyloidosis, and cast nephropathy in a patient with multiple myeloma].
    Rekhtina IG; Zakharova EV; Stolyarevich ES; Sinitsina MN; Denisova EN
    Ter Arkh; 2015; 87(6):98-101. PubMed ID: 26281203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Light chain deposition disease without glomerular proteinuria: a diagnostic challenge for the nephrologist.
    Sicard A; Karras A; Goujon JM; Sirac C; Bender S; Labatut D; Callard P; Sarkozy C; Essig M; Vanhille P; Provot F; Nony A; Nochy D; Ronco P; Bridoux F; Touchard G
    Nephrol Dial Transplant; 2014 Oct; 29(10):1894-902. PubMed ID: 24619059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].
    Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J
    Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphologic manifestations of combined light-chain deposition disease and light-chain cast nephropathy.
    Gokden N; Cetin N; Colakoglu N; Kumar J; Abul-Ezz S; Barlogie B; Liapis H; Walker PD
    Ultrastruct Pathol; 2007; 31(2):141-9. PubMed ID: 17613994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
    Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
    Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal failure due to combined cast nephropathy, amyloidosis and light-chain deposition disease.
    Lorenz EC; Sethi S; Poshusta TL; Ramirez-Alvarado M; Kumar S; Lager DJ; Fervenza FC; Leung N
    Nephrol Dial Transplant; 2010 Apr; 25(4):1340-3. PubMed ID: 20061318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and prognostic factors in multiple myeloma patients with light chain deposition disease.
    Mohan M; Buros A; Mathur P; Gokden N; Singh M; Susanibar S; Jo Kamimoto J; Hoque S; Radhakrishnan M; Matin A; Davis C; Grazziutti M; Thanendrarajan S; van Rhee F; Zangari M; Davies F; Morgan G; Epstein J; Barlogie B; Schinke C
    Am J Hematol; 2017 Aug; 92(8):739-745. PubMed ID: 28383130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AL-amyloidosis and light-chain deposition disease light chains induce divergent phenotypic transformations of human mesangial cells.
    Keeling J; Teng J; Herrera GA
    Lab Invest; 2004 Oct; 84(10):1322-38. PubMed ID: 15286662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal monoclonal immunoglobulin deposition disease: the disease spectrum.
    Lin J; Markowitz GS; Valeri AM; Kambham N; Sherman WH; Appel GB; D'Agati VD
    J Am Soc Nephrol; 2001 Jul; 12(7):1482-1492. PubMed ID: 11423577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ultrastructural and immunoelectron microscopic study on light chain deposition diseases and primary amyloidosis of the kidney].
    Wang S; Zou W; Wang M; Xie Y; Chai L; Tang X
    Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Dec; 35(6):576-80. PubMed ID: 14710247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of rapidly progressive liver light chain deposition under VAD chemotherapy in multiple myeloma.
    Samanez C; Domingo A; Cibeira MT; Miquel R; Soler M; Bladé J
    Eur J Haematol; 2006 Jan; 76(1):83-5. PubMed ID: 16343276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological features and outcomes of coexistent light chain cast nephropathy and light chain deposition disease in patients with newly diagnosed multiple myeloma.
    Lin ZS; Zhang X; Li DY; Yu XJ; Qin AB; Dong Y; Zhou FD; Wang S; Zhao MH
    J Clin Pathol; 2021 Jun; ():. PubMed ID: 34187849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of nephrotic syndrome induced by lambda light chain deposition disease using lenalidomide: A case report and review of the literature
.
    Mima A; Nagahara D; Tansho K
    Clin Nephrol; 2018 Jun; 89(6):461-468. PubMed ID: 29393843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and prognostic differences among patients with light chain deposition disease, myeloma cast nephropathy and both.
    Zand L; Nasr SH; Gertz MA; Dispenzieri A; Lacy MQ; Buadi FK; Kumar S; Kyle RA; Fervenza FC; Sethi S; Dingli D; Rajkumar SV; Kapoor P; McCurdy A; Leung N
    Leuk Lymphoma; 2015; 56(12):3357-64. PubMed ID: 25860232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis.
    Buxbaum JN; Chuba JV; Hellman GC; Solomon A; Gallo GR
    Ann Intern Med; 1990 Mar; 112(6):455-64. PubMed ID: 2106817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal amyloidosis complicated by light chain deposition nephropathy: a case report.
    Yu X; Lan P; Feng J; Feng X; Xie L
    Int J Clin Exp Pathol; 2019; 12(6):2279-2283. PubMed ID: 31934052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloma cast nephropathy with diffuse amyloid casts without systemic amyloidosis: two cases report.
    Yong ZH; Yu XJ; Lin ZS; Zhou FD; Cen XN; Wang SX; Zhao MH
    BMC Nephrol; 2021 Jan; 22(1):6. PubMed ID: 33407225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of light chain deposition nephropathy relative to renal amyloidosis and Bence Jones cast nephropathy in a necropsy study of patients with myeloma.
    Iványi B
    Arch Pathol Lab Med; 1990 Sep; 114(9):986-7. PubMed ID: 2117910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.